ADAG
Adagene Inc.
NASDAQ · Healthcare · Biotechnology · CN
$3.58
−2.98%Next report
Analyst consensus
- Next report date
- Mar 31, 2027
- EPS estimate
- -$0.22
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 12, 2026
- EPS actual
- -$0.23
- EPS estimate
- -$0.23
- Revenue actual
- $1.6M
- Revenue estimate
- $1.6M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 3
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +15.1%
- Revenue beats (12Q)
- 0
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Mar 31, 2027